Modulatory Role of Omentin-1 in Inflammation: Cytokines and Dietary Intake

REFERENCES

• Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN: National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 377:557–567, 2011.
   PubMed Web of Science ®Google Scholar
• Esteghamati A, Khalilzadeh O, Mohammad K, Meysamie A, Rashidi A, Kamgar M, Abbasi M, Asgari F, Haghazali M: Secular trends of obesity in Iran between 1999 and 2007: national surveys of risk factors of non-communicable diseases. Metab Syndr Relat Disord 8:209–213, 2010.
   PubMed Web of Science ®Google Scholar
• Chan JM, Rimm EB, Colditz GA, Stampfer MJ, Willett WC: Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 17:961–969, 1994.
   PubMed Web of Science ®Google Scholar
• Hubert HB, Feinleib M, McNamara PM, Castelli WP: Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67:968–977, 1983.
   PubMed Web of Science ®Google Scholar
• Carroll K: Obesity as a risk factor for certain types of cancer. Lipids 33:1055–1059, 1998.
   PubMed Web of Science ®Google Scholar
• Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, Sole J, Nichols A, Ross JS, Tartaglia LA: Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112:1821–1830, 2003.
   PubMed Web of Science ®Google Scholar
• Yudkin JS, Stehouwer C, Emeis J, Coppack S: C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 19:972–978, 1999.
   PubMed Web of Science ®Google Scholar
• Ferri C, Desideri G, Valenti M, Bellini C, Pasin M, Santucci A, De Mattia G: Early upregulation of endothelial adhesion molecules in obese hypertensive men. Hypertension 34:568–573, 1999.
   PubMed Web of Science ®Google Scholar
• Yamawaki H: Vascular effects of novel adipocytokines: focus on vascular contractility and inflammatory responses. Biol Pharm Bull 34:307–310, 2011.
   PubMed Web of Science ®Google Scholar
• Yang R-Z, Lee M-J, Hu H, Pray J, Wu H-B, Hansen BC, Shuldiner AR, Fried SK, McLenithan JC, Gong D-W: Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab 290:E1253–E1261, 2006.
   PubMed Web of Science ®Google Scholar
• Yang R, Xu A, Pray J, Hong H, Jadhao S, Hansen B, Shuldiner A, McLenithan J, Gong D: “Cloning of Omentin, a New Adipocytokine from Omental Fat Tissue in Humans.” Alexandria, VA: American Diabetes Association, 2003.
   Google Scholar
• de Souza Batista CM, Yang R-Z, Lee M-J, Glynn NM, Yu D-Z, Pray J, Ndubuizu K, Patil S, Schwartz A, Kligman M: Omentin plasma levels and gene expression are decreased in obesity. Diabetes 56:1655–1661, 2007.
   PubMed Web of Science ®Google Scholar
• Auguet T, Quintero Y, Riesco D, Morancho B, Terra X, Crescenti A, Broch M, Aguilar C, Olona M, Porras JA: New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med Genet 12:60, 2011.
   Google Scholar
• Moreno-Navarrete JM, Catalán V, Ortega F, Gómez-Ambrosi J, Ricart W, Frühbeck G, Fernández-Real JM: Circulating omentin concentration increases after weight loss. Nutr Metab (Lond) 7:27–32, 2010.
   Google Scholar
• Pan H-Y, Guo L, Li Q: Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes. Diabetes Res Clin Pract 88:29–33, 2010.
   PubMed Web of Science ®Google Scholar
• Zhong X, Zhang H-y, Tan H, Zhou Y, Liu F-l, Chen F-q, Shang D-y: Association of serum omentin-1 levels with coronary artery disease. Acta Pharmacol Sin 32:873–878, 2011.
   PubMed Web of Science ®Google Scholar
• Yamawaki H, Kuramoto J, Kameshima S, Usui T, Okada M, Hara Y: Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem Biophys Res Commun 408:339–343, 2011.
   PubMed Web of Science ®Google Scholar
• Zhong X, Li X, Liu F, Tan H, Shang D: Omentin inhibits TNF-α-induced expression of adhesion molecules in endothelial cells via ERK/NF-κB pathway. Biochem Biophys Res Commun 425:401–406, 2012.
   PubMed Web of Science ®Google Scholar
• Kazama K, Usui T, Okada M, Hara Y, Yamawaki H: Omentin plays an anti-inflammatory role through inhibition of TNF-α-induced superoxide production in vascular smooth muscle cells. Eur J Pharmacol 686:116–123, 2012.
   PubMed Web of Science ®Google Scholar
• Maruyama S, Shibata R, Kikuchi R, Izumiya Y, Rokutanda T, Araki S, Kataoka Y, Ohashi K, Daida H, Kihara S: Fat-derived factor omentin stimulates endothelial cell function and ischemia-induced revascularization via endothelial nitric oxide synthase–dependent mechanism. J Biol Chem 287:408–417, 2012.
   PubMed Web of Science ®Google Scholar
• Bienertová-Vašků J, Novák J, Zlámal F, Forejt M, Havlenová S,Jackowská A, Tomandl J, Tomandlová M, Šplíchal Z, Vašků A: The prediction role of indexes of circulating adipokines for common anthropometric and nutritional characteristics of obesity in the obese Central European population. Eat Behav 15:244–251, 2014.
   PubMed Web of Science ®Google Scholar
• Hermsdorff HHM, Zulet Mn, Puchau B, Bressan J, Martínez JA: Association of retinol-binding protein-4 with dietary selenium intake and other lifestyle features in young healthy women. Nutrition 25:392–399, 2009.
   PubMed Web of Science ®Google Scholar
• Hřebíček J, Janout V, Malinčíková J, Horáková D, Čížek L: Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab 87:144–7, 2002.
   Google Scholar
• Mirzaei K, Hossein-nezhad A, Emamgholipour S, Ansar H, Khosrofar M, Tootee A, Alatab S: An exonic peroxisome proliferator–activated receptor-γ coactivator-1α variation may mediate the resting energy expenditure through a potential regulatory role on important gene expression in this pathway. J Nutrigenet Nutrigenomics 5:59–71, 2011.
   Web of Science ®Google Scholar
• Krauss RM, Deckelbaum RJ, Ernst N, Fisher E, Howard BV, Knopp RH, Kotchen T, Lichtenstein AH, McGill HC, Pearson TA, Prewitt TE, Stone NJ, Van Horn L, Weinberg R: Dietary guidelines for healthy American adults. A statement for health professionals from the Nutrition Committee, American Heart Association. Circulation 94:1795–1800, 1996.
   PubMed Web of Science ®Google Scholar
• Liu R, Wang X, Bu P: Omentin-1 is associated with carotid atherosclerosis in patients with metabolic syndrome. Diabetes Res Clin Pract 93:21–25, 2011.
   PubMed Web of Science ®Google Scholar
• Urbanová M, Dostálová I, Trachta P, Drápalová J, Kaválková P, Haluzíková D, Matoulek M, Lacinová Z, Mráz M, Kasalický M: Serum concentrations and subcutaneous adipose tissue mRNA expression of omentin in morbid obesity and type 2 diabetes mellitus: the effect of very-low-calorie diet, physical activity and laparoscopic sleeve gastrectomy. Physiol Res 63:207–218, 2014.
   PubMed Web of Science ®Google Scholar
• Yan P, Liu D, Long M, Ren Y, Pang J, Li R: Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes 119:257–263, 2011.
   PubMed Web of Science ®Google Scholar
• Tan BK, Pua S, Syed F, Lewandowski K, O'Hare JP, Randeva HS: Decreased plasma omentin‐1 levels in type 1 diabetes mellitus. Diabet Med 25:1254–1255, 2008.
   PubMed Web of Science ®Google Scholar
• Nehete P, Magden ER, Nehete B, Hanley PW, Abee CR: Obesity related alterations in plasma cytokines and metabolic hormones in chimpanzees. Int J Inflamm 2014: 2014.
   PubMedGoogle Scholar
• Charles A: Biologic basis for interleukin-1 in disease. Blood 87:2095–2147, 1996.
   PubMed Web of Science ®Google Scholar
• Kwon H, Laurent S, Tang Y, Zong H, Vemulapalli P, Pessin JE: Adipocyte-specific IKKβ signaling suppresses adipose tissue inflammation through an IL-13-dependent paracrine feedback pathway. Cell Rep 9:1574–1583, 2014.
   PubMed Web of Science ®Google Scholar
• Du R, Zhao H, Yan F, Li H: IL-17+ Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cells. J Leukoc Biol 96:39–48, 2014.
   PubMed Web of Science ®Google Scholar
• Lapointe M, Poirier P, Martin J, Bastien M, Auclair A, Cianflone K: Omentin changes following bariatric surgery and predictive links with biomarkers for risk of cardiovascular disease. Cardiovasc Diabetol 13:124, 2014.
   PubMed Web of Science ®Google Scholar
• Li X, Zeng S, Wang M, Wu X, Liao E: Relationships between serum omentin-1, body fat mass and bone mineral density in healthy Chinese male adults in Changsha area. J Endocrinol Invest 37:991–1000, 2014.
   PubMed Web of Science ®Google Scholar
• Vu A, Sidhom MS, Bredbeck BC, Kosmiski LA, Aquilante CL: Evaluation of the relationship between circulating omentin-1 concentrations and components of the metabolic syndrome in adults without type 2 diabetes or cardiovascular disease. Diabetol Metab Syndr 6:4, 2014.
   PubMed Web of Science ®Google Scholar
• Hajer GR, van Haeften TW, Visseren FL: Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur Heart J 29:2959–2971, 2008.
   PubMed Web of Science ®Google Scholar
• Wang Z, Nakayama T: Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm 2010: 2010.
   Web of Science ®Google Scholar